Immucell ICCC
NASDAQ ICCC
$9.91 +0.01 (+0.05%)
At close: Sep 10, 2026 · 4:00 PM EDT

Immucell (ICCC) Operating Margin Growth (1y) (2011 - 2026)

Analysis

Immucell (ICCC) Operating Margin Growth (1y) (2011 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (1y) (Qtr)
1 Idexx Laboratories 39.99 Bn 39.79 Bn 779.09 Mn 136.00
2 Zoetis 30.50 Bn 28.83 Bn 1.05 Bn -368.00
3 Elanco Animal Health 11.44 Bn 10.91 Bn 798.00 Mn 40.00
4 Phibro Animal Health 1.48 Bn 1.40 Bn 134.40 Mn 323.00
5 Immucell 89.38 Mn 80.52 Mn 2.44 Mn 1,809.00
6 Zhengye Biotechnology Holding 74.34 Mn 67.24 Mn - -
7 Global Innovative Platforms 24.88 Mn 24.63 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1,809.00
Dec 31, 2025 -878.00
Sep 30, 2025 993.00
Jun 30, 2025 3,417.00
Mar 31, 2025 1,799.00
Sep 30, 2024 1,238.00
Jun 30, 2024 1,159.00
Mar 31, 2024 6,132.00
Sep 30, 2023 -908.00
Jun 30, 2023 -2,090.00
Mar 31, 2023 -7,497.00
Dec 31, 2022 -4,445.00
Sep 30, 2022 -1,812.00
Jun 30, 2022 -2,078.00
Mar 31, 2022 1,863.00
Dec 31, 2021 1,962.00
Sep 30, 2021 1,202.00
Jun 30, 2021 2,805.00
Mar 31, 2021 -1,313.00
Dec 31, 2020 -1,027.00